Şunu aradınız:: mlaqqmin (Maltaca - İngilizce)

persuni mlaqqmin immunokompetenti
immunocompetent vaccinees

persuni mlaqqmin immunokompromessi (eż. pazjenti b’ dijaliżi, pazjenti bi trapjanti)
immunocompromised vaccinees (e. g. dialysis patients, transplant patients)

Żwiemel b’saħħithom biss li qegħdin f’riskju li jieħdu infezzjoni għandhom jiġu mlaqqmin.
only healthy horses which are at risk of infection should be vaccinated.

iż-żwiemel kollha għandhom jiġu mlaqqmin mill-ġdid kull tliet xhur sabiex iżommu l-immunità.
all horses should be revaccinated every three months to maintain immunity.

huwa essenzjali li jittieħdu miżuri biex titnaqqas l-espożizzjoni għal ‘sandflies’ f’annimali mlaqqmin.
it is essential that measures to reduce exposure to sand-flies are employed in vaccinated animals.

Żewġ (2) suġġetti mlaqqmin b' zostavax esperjenzaw problemi fil- viżta kontra 9 li rċevew placebo.
9 who received placebo.

ladarba mlaqqmin, il-klieb nisa jgħaddu dawn l-antikorpi lill- ġriewi permezz tal-ħalib tagħhom.
once vaccinated, bitches will, through colostrum, give those antibodies to puppies.

tromboċitopenja għad m’ hemmx tagħrif kliniku fuq l- iżvilupp jew iggravar ta 'thromboċitopenja f' individwi mlaqqmin bi proquad.
thrombocytopenia no clinical data are available regarding the development or worsening of thrombocytopenia in individuals vaccinated with proquad.

il-kategoriji speċifiċi ta’ nies li jinsabu f’riskju u li għandhom jiġu mlaqqmin għandhom jiġu stabbiliti skont ir-rakkomandazzjonijiet uffiċjali.
the specific at risk categories to be immunised are to be determined on the basis of the official recommendations.

f’annimali tal-laboratorju, ma dehret ebda reazzjoni avversa fi fniek maternali mlaqqmin jew fil-friegħ tagħhom sa jum 29 wara t-twelid tagħhom.
in laboratory animals, no adverse reactions were seen in vaccinated maternal rabbits or in their offspring through postnatal day 29.

in vivo, docetaxel jaħdem indipendentement mill-iskeda ta’ kif jingħata u għandu firxa wiesgħa t’attivita fuq it-tumuri esperimentali, kontra tumuri mlaqqmin u avvanzati derivati mill- ġrieden u mill-bnedmin.
in vivo, docetaxel is schedule independent and has a broad spectrum of experimental antitumour activity against advanced murine and human grafted tumours.